Matthias Aizenberg

Matthias Aizenberg

Healthcare Innovation Consultant
Matthias Aizenberg is a seasoned expert in the Healthcare industry. He explores digital health, clinical processes, and healthcare management strategies. Matthias has a deep interest in pharmaceutical and healthcare innovation and is a well-trusted resource for biopharma professionals.
Infection Risk: CAR T-Cell vs. Bispecific Antibodies?
Research & Development Infection Risk: CAR T-Cell vs. Bispecific Antibodies?

Unlike the single-infusion protocol of CAR T-cells, the repeated administration of bispecific antibodies may prevent the immune system from achieving full recovery. This observation has become central to oncological discussions in 2026 as these advanced immunotherapies dominate the treatment

Privacy-Aware Assisted Living – Review
Tech & Innovation Privacy-Aware Assisted Living – Review

The quiet transition of a private residence into a sophisticated, semi-clinical environment has become a defining characteristic of modern elder care, yet the persistent friction between radical transparency and individual dignity remains largely unresolved. As the population continues to age, the

Symbolic Neural Generation Advances Lead Discovery in Drug Design
Tech & Innovation Symbolic Neural Generation Advances Lead Discovery in Drug Design

By leveraging a system of base and fibre posets, computational chemists can now characterize the search space for new drugs with mathematical precision and formal semantics. The pharmaceutical industry is currently witnessing a significant shift as artificial intelligence moves from being an

How Is Tandem Health Scaling AI Across European Healthcare?
Tech & Innovation How Is Tandem Health Scaling AI Across European Healthcare?

Before a patient even enters the room, Tandem Health’s AI synthesizes complex medical histories into concise summaries to streamline the clinical consultation process. This innovative approach has paved the way for the Stockholm-based company to secure a landmark $100 million Series B funding

How Can Data Drive Sustainable Oral Drug Delivery?
Management & Regulatory How Can Data Drive Sustainable Oral Drug Delivery?

Refining spray drying setups to enhance energy efficiency serves as a primary manufacturing lever for reducing the global warming potential of oral drug delivery components. This technical advancement reflects a broader trend where the pharmaceutical industry is navigating a pivotal transition to

How Does Proteomic Research Advance Pediatric Brain Cancer Care?
Research & Development How Does Proteomic Research Advance Pediatric Brain Cancer Care?

Medulloblastoma is often the result of epigenetic malfunctions rather than direct DNA mutations, requiring a specialized focus on how genetic material is controlled. Medulloblastoma remains a formidable adversary in pediatric oncology, accounting for a significant portion of high-grade brain tumors

Moving Beyond Benchmarks for Safe Clinical AI Deployment
Research & Development Moving Beyond Benchmarks for Safe Clinical AI Deployment

Prospective trials must be specifically designed to capture failure modes and edge-case behaviors rather than simply replicating success rates in controlled environments. As we navigate the complex landscape of 2026, the healthcare sector is increasingly saturated with Large Language Models that

Can a New Combo Treatment Transform Myeloma Care?
Research & Development Can a New Combo Treatment Transform Myeloma Care?

The medical community recently witnessed a monumental shift in blood cancer treatment as the National Institute for Health and Care Excellence issued a recommendation that could fundamentally alter the trajectory of thousands of lives. By endorsing the quadruple combination of daratumumab,

How Will VivoSim’s AI Change Pharmaceutical Development?
Research & Development How Will VivoSim’s AI Change Pharmaceutical Development?

The emergence of New Approach Methodologies is driven by both a need for higher scientific accuracy and the ethical considerations surrounding traditional laboratory testing. As drug developers navigate an increasingly complex landscape where costs for a single successful launch often exceed two

Biosecurity Emerges as a Leading Global Security Challenge
Tech & Innovation Biosecurity Emerges as a Leading Global Security Challenge

The integration of artificial intelligence into biological research enables the analysis of vast datasets to accelerate both life-saving cures and the potential engineering of biological weapons. This dual nature of modern science has transformed the way governments perceive national safety and

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later